NMRA | | Neumora Therapeutics, Inc. | Gosebruch Henry O | President & CEO | Sep 19, 2023 | Buy | $12.62 | 15,000 | 189,370 | 15,000 | Sep 19, 2023, 09:47 PM |
SLRN | | ACELYRIN, Inc. | Gosebruch Henry O | Director | May 09, 2023 | Buy | $18.00 | 50,000 | 900,000 | 50,000 | May 11, 2023, 09:06 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | May 16, 2022 | Sale | $104.93 | 167,920 | 17,619,846 | 125,583 | May 20, 2022, 05:03 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | Mar 01, 2022 | Sale | $147.29 | 25,000 | 3,682,199 | 62,767 | May 20, 2022, 05:00 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | May 16, 2022 | Option Exercise | $104.93 | 167,920 | 17,619,846 | 100,583 | May 18, 2022, 05:12 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | Mar 01, 2022 | Sale | $147.29 | 25,000 | 3,682,199 | 25,890 | Mar 02, 2022, 05:03 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | Feb 25, 2022 | Option Exercise | $149.54 | 30,156 | 4,509,528 | 56,623 | Mar 01, 2022, 06:14 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | Mar 01, 2022 | Sale | $148.26 | 15,000 | 2,223,833 | 51,027 | Mar 01, 2022, 06:14 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | Feb 28, 2021 | Option Exercise | $107.74 | 22,833 | 2,460,027 | 48,711 | Mar 02, 2021, 08:34 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | Nov 20, 2020 | Sale | $99.38 | 40,000 | 3,975,046 | 53,106 | Nov 24, 2020, 05:34 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | Feb 28, 2020 | Option Exercise | $85.42 | 26,038 | 2,224,166 | 78,506 | Mar 03, 2020, 04:53 PM |
APTX | | Aptinyx Inc. | Gosebruch Henry O | Director | Jan 10, 2020 | Buy | $3.00 | 25,000 | 75,000 | 125,000 | Jan 14, 2020, 04:19 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | Jul 29, 2019 | Buy | $67.28 | 30,000 | 2,018,385 | 75,763 | Jul 31, 2019, 04:46 PM |
APTX | | Aptinyx Inc. | Gosebruch Henry O | Director | May 07, 2019 | Buy | $3.75 | 3,420 | 12,825 | 3,420 | May 09, 2019, 10:01 AM |
APTX | | Aptinyx Inc. | Gosebruch Henry O | Director | May 08, 2019 | Buy | $3.86 | 96,580 | 372,799 | 100,000 | May 09, 2019, 10:01 AM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | Feb 28, 2019 | Option Exercise | $79.41 | 22,956 | 1,822,936 | 45,763 | Mar 04, 2019, 04:55 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | Dec 09, 2018 | Option Exercise | $86.96 | 13,446 | 1,169,264 | 16,904 | Dec 11, 2018, 04:59 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | Nov 29, 2018 | Sale | $90.10 | 42,450 | 3,824,940 | 30,350 | Nov 30, 2018, 05:22 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy Officer | Feb 28, 2018 | Option Exercise | $118.26 | 17,418 | 2,059,853 | 72,800 | Mar 02, 2018, 05:29 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Officer | Dec 09, 2017 | Option Exercise | $95.95 | 14,235 | 1,365,848 | 50,902 | Dec 11, 2017, 05:23 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Officer | Oct 30, 2017 | Sale | $90.55 | 18,300 | 1,657,037 | 81,287 | Oct 31, 2017, 05:04 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Officer | Jul 31, 2017 | Sale | $70.42 | 300 | 21,127 | 83,637 | Aug 02, 2017, 05:06 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Officer | Jul 31, 2017 | Sale | $70.09 | 18,000 | 1,261,638 | 96,074 | Aug 02, 2017, 05:05 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Officer | Feb 28, 2017 | Option Exercise | $62.22 | 20,673 | 1,286,274 | 101,737 | Mar 02, 2017, 06:12 PM |
ABBV | | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Officer | Dec 09, 2016 | Option Exercise | $60.90 | 13,871 | 844,744 | 77,179 | Dec 09, 2016, 05:08 PM |